Hypoxic tumors are sensitive to FLASH radiotherapy
R. J. Leavitt, A. Almeida, V. Grilj, P. Montay-Gruel, C. Godfroid, B. Petit, C. Bailat, C. L. Limoli, M.-C. Vozenin
This study shows FLASH radiotherapy retains anti-tumor efficacy under extreme hypoxia, overcoming resistance seen with conventional RT.
bioRxiv · Nov 27, 2022 · PreprintCancer Biology